Was ist der unterschied zwischen pharma und diagnostics

Beitrag von Cindy Perettie

Andere Beiträge von Cindy anzeigen

• Thank you Tal for sharing, we are very excited to have an engaging conversation around liquid biopsy and the impact it has had to date as well as what is possible tomorrow.

  Co-founder & President, PMWC Intl / 30,000 Followers

  1 Woche Bearbeitet

  A Note from Cindy Perettie (Roche) #PMWC23 Liquid Biopsy Track   The biggest winner of COVID was #liquidbiopsy (LB), as interventional surgeries for biopsies simply weren’t happening during much of the pandemic. LB was a phenomenal solution and the restrictions due to #covid19 certainly propelled its advancement during the last couple of years. I certainly believe LB wouldn’t have had the same opportunity if it weren’t for COVID.   And then, of course, LB will enable earlier cancer detection – a very critical aspect that will reduce the need for invasive diagnostic procedures that more typically are triggered by severe symptoms related to later-stage cancers. Routine early cancer screening has been shown to have a tremendous impact on patient survival rate and overall treatment cost – a plus for the entire healthcare community.   Lastly, another hot topic is cancer prediction. Determining whether we can identify the tumor of origin with Minimal Residual Disease (MRD) testing, via cell-free DNA analysis, is a big focus area – fragmentomics and proteomics play a huge role here. Certainly, we are still facing numerous challenges that we need to overcome, which is one of the main objectives for the PMWC January 25-27, 2023 Silicon Valley conference for getting the different stakeholders into one room to expedite the identification and delivery of possible solutions to those challenges.   I am so excited to chair the “Clinical Utility of Liquid Biopsies” track 4 at PMWC 2023 Silicon Valley, on January 26. We have an exciting program put together that promises to touch on all those critical aspects. Here are some program highlights: • Non-invasive Liquid Biopsy Techniques (PANEL) –chaired by Razelle Kurzrock (Medical College of Wisconsin) with Apostolia M Tsimberidou (MD Anderson), Mandana Kamgar (Medical College of Wisconsin), Mina Nikanjam (UCSD), and Ash Alizadeh (Stanford University) • Liquid Biopsy Challenges and Limitations (PANEL) –with @Victor Lin, (Mary Bird Perkins Cancer Center), Dana Dilbeck (Agilent Technologies), Luis Alberto Diaz Jr. (MSK) and Max Diehn (Stanford) • Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL) –chaired by Cindy Perettie (Roche Diagnostics) with Andrew McKenzie (Sarah Cannon), Eric Peters (Genentech) and Carl Barrett (AZ) • Liquid Biopsy for early cancer detection- Chaired by Priti Hegde, Foundation Medicine. Panelists: Daniel Kim, UCSC, Mike Nolan, Freenome, Jeffrey Venstrom, GRAIL Bio, Lon Castle, eviCore healthcare, Kathryn Phillips, UCSF and Tom Beer, Exact Sciences • Liquid Biopsy for Minimal Residual Disease (MRD) – chaired by Minetta Liu (Natera) panelists: Peter Bach (Delfi Diagnostics), Laura van 't Veer (UCSF), and Nitin Sood (Adaptive Bio)   I hope to see many of you Join us for this most exciting track. PMWC LLC - Precision Medicine World Conference

  Loggen Sie sich ein, um Kommentare zu sehen oder hinzuzufügen.

• So happy that we can honor Dr. Razelle Kurzrock for all of her important contributions in pioneering approaches precision medicine! Please join us at PMWC.

  Co-founder & President, PMWC Intl / 30,000 Followers

  3 Wochen

  PMWC is proud to award Dr. Razelle Kurzrock (Medical College of Wisconsin) for pioneering precision medicine #clinicaltrials and studies in the US and around the world, and the use of #liquidbiopsy to predict #immunotherapy. The award ceremony will be held on January 26, 9am at the #PMWC2023 Silicon Valley. Prior award recipients include Dr. Albert Bourla, Dr. Stephen Hoge, Dr. Stephen Kingsmore, and Dr. Özlem Türeci. Join me in congratulating her! Dr. Kurzrock will also chair two sessions at the conference: 1. Novel Clinical Trial Designs (PANEL) with Sicklick Jason, UCSD, Jim Palma, TargetCancer Foundation, Corrie Painter, 4:59 NewCo, a 5AM Ventures Company and Laura Esserman, UCSF 2. The Non-invasive Liquid Biopsy Techniques. Panelists include Apostolia M Tsimberidou (MD Anderson), Mandana Kamgar (Medical College of Wisconsin), Mina Nikanjam (UCSD), and Ash Alizadeh (Stanford University). Other notable sessions in the Clinical Utility of Liquid Biopsies Track include: Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL). Chaired by Cindy Perettie (Roche Diagnostics); Panelists are Andrew McKenzie (Sarah Cannon) and J.Carl Barrett (Astra Zeneca). Liquid Biopsy for Early Cancer Detection (PANEL). Chaired by Priti Hegde (Foundation Medicine); Panelists are Daniel Kim (UCSC), Mike Nolan (Freenome), Jeffrey Venstrom, M.D. (GRAIL Bio), Kathryn Phillips (UCSF), Lon Castle (eviCore healthcare). Liquid Biopsy for Minimal Residual Disease (PANEL). Chaired by Minetta Liu (Natera), Peter B. (Delfi Diagnostics), Laura van 't Veer (UCSF), Nitin Sood (Adaptive Biotechnologies Corp.). For more information: https://bit.ly/3FaS4Wp PMWC LLC - Precision Medicine World Conference

  Loggen Sie sich ein, um Kommentare zu sehen oder hinzuzufügen.

• I am delighted to serve as a chair of the 22nd Precision Medicine World Conference 2023 Silicon Valley in the Next Generation Technologies/ Clinical Utility of Liquid Biopsy Track 4, on January 26. Look forward to kicking the program by introducing and handing the PMWC 2023 Pioneer Award to Razelle Kurzrock for  Pioneering precision medicine clinical trials & studies in the US and around the world, and the use of liquid biopsy to predict immunotherapy. I had the privilege to work with Dr. Kurzrock while I led Foundation Medicine and was impressed by her commitment to precision care for all patients as well as advancing Woman in Science. We would also be honoring Luis Diaz for his assistance in pioneering the application of circulating tumor DNA as a cancer diagnostic and a strategy for monitoring the emergence of therapeutic resistance in the blood. Here is a short summary of the sessions I assisted in creating with its confirmed participants: Non-invasive Liquid Biopsy Techniques (PANEL) Chaired by Razelle Kurzrock, Medical College of Wisconsin Joining her on stage: Apostolia M Tsimberidou Tsimberidou, MD Anderson,  Mandana Kamgar, MD Medical College of Wisconsin Mina Nikanjam, UCSD Ash Alizadeh, Stanford University Liquid Biopsy in Clinical Trials: Learnings and COVID Experience (PANEL) Chaired by me and joined by Andrew Mckenzie, Sarah Cannon, and Carl Barrett, Astra Zeneca Liquid Biopsy for early cancer detection (PANEL) Chaired by Priti Hegde, Foundation Medicine Panelists include:  Mike Nolan, Freenome Jeffrey Venstrom, M.D. Grail Bio Lon Castle, eviCore healthcare Kathryn Phillips, UCSF Liquid Biopsy for Minimal Residual Disease (PANEL) Chaired by Minetta L. Liu, Natera Joined by Peter Bach, Delfi diagnostics Laura Vantveer, UCSF Nitin Sood, Adaptive Joshua Cohen, Johns Hopkins See full agenda: https://bit.ly/3UAQbI6 Hope you join me at PMWC 2023!

  Silicon Valley Program

  https://www.pmwcintl.com

  Loggen Sie sich ein, um Kommentare zu sehen oder hinzuzufügen.

• I am very excited to be joining the Longwood Meeting On September 21st and 22nd and participating in a panel "Creating a World Without Disease". Excited to be joined by so many impactful leaders for this panel; Anne Klibanski, Peter Lebowitz, Richard Paulson, Jan Pinkas, and Chen Schor for this great discussion.

  Loggen Sie sich ein, um Kommentare zu sehen oder hinzuzufügen.

• Come join our great team in San Jose as a Lab Director, it is a important role that will have strong impact for patients and for Roche.

  I am excited to share that we have a lab director position open at our Roche San Jose site! It is a great opportunity for making a significant impact for our pharma partners and ultimately our patients. https://lnkd.in/gf4_VXB6

  Director, CLIA Laboratory

  roche.wd3.myworkdayjobs.com

  Loggen Sie sich ein, um Kommentare zu sehen oder hinzuzufügen.

Mehr von diesem:dieser Autor:in